Apolipoprotein and anticardiolipin antibodies in patients with renal amyloidosis

Cengiz K., Kilic M., Bedir A.

NEPHROLOGY, vol.9, no.3, pp.118-121, 2004 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 3
  • Publication Date: 2004
  • Doi Number: 10.1111/j.1440-1797.2004.00241.x
  • Journal Name: NEPHROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.118-121
  • Keywords: amyloidosis, anticardiolipin antibody, apolipoproteins, chronic renal failure, SYSTEMIC LUPUS-ERYTHEMATOSUS, LOW-DENSITY-LIPOPROTEIN, HEMODIALYSIS-PATIENTS, SERUM-ALBUMIN, ANTIPHOSPHOLIPID ANTIBODIES, A-I, CARDIOLIPIN, THROMBOSIS, FEATURES, PROTEIN
  • Ondokuz Mayıs University Affiliated: No

Abstract

Background: Thromboembolic events are seen more frequently in patients with chronic renal failure (CRF) and amyloidosis. The anticardiolipin antibody (ACA) that is important for thromboembolic events has never been studied.